Search
for
Sort by
Research 31–60 of 38
- Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3
- Mutations in SNRPE, which Encodes a Core Protein of the Spliceosome, Cause Autosomal-Dominant Hypotrichosis Simplex
- Monilethrix: A Novel Mutation (Glu402Lys) in the Helix Termination Motif and the First Causative Mutation (Asn114Asp) in the Helix Initiation Motif of the Type II Hair Keratin hHb6
- Response to Ranpariya et al.’s “Direct-to-consumer teledermatology platforms may have inherent conflicts of interest.”
- Direct-to-consumer teledermatology’s limitations may be addressed with greater in-person care synergy
- Brigham Eyebrow Tool for Alopecia: A Reliable Assessment of Eyebrow Alopecia Areata
- Validation of alopecia coding in US claims data among women of childbearing age
- Addressing Autoimmune and Immune-mediated Skin Disease Burden in Women
- Comparison of Microneedling with Platelet Rich Plasma vs Minoxidil (5%)+Finasteride (0.1%) Topical Therapy in Androgenetic Alopecia: A Randomised Clinical Study
- Patient satisfaction, side effects, and other reactions reported by adult men prescribed compounded, topical finasteride via a national telehealth platform: A retrospective analysis of real world data (Preprint)
- Patient satisfaction, side effects, and other reactions reported by adult men prescribed compounded, topical finasteride via a national telehealth platform: A retrospective analysis of real world data (Preprint)
- Online Traffic Analysis of Direct-to-Consumer Websites for Hair Loss Treatment and Characterization of Finasteride Patients on a Platform in Germany: A Potential Paradigm Shift in the Treatment of Androgenetic Alopecia
- Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study
- Treatment Patterns and Treatment Satisfaction Among Adults with Alopecia Areata in the United States
- Digital health platforms expand access and improve care for male androgenetic alopecia
- Factors influencing alopecia areata treatment decisions: A qualitative assessment
- Gender based price differences in 5% minoxidil foam: The impact of generic alternatives and bulk packaging
- Local Corticosteroids for Alopecia Areata: A Narrative Review
- Association Between Natural Hair Color, Race, and Alopecia
- A mutation in the type II hair keratin KRT86 gene in a Han family with monilethrix
- Exploring Factors That Influence the Measurement of Patient-Reported Impacts of Alopecia Areata
- Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Efficacité à long terme du baricitinib dans le traitement de la pelade : résultats à la semaine 104 des études BRAVE-AA1 et BRAVE-AA2
- Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies
- Evaluation of Stigma Toward Individuals With Alopecia
- The Association of Alopecia Areata-Related Emotional Symptoms with Work Productivity and Daily Activity Among Patients with Alopecia Areata
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Association of resilience and perceived stress in patients with alopecia areata: A cross-sectional study
- Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment